MedWatch

Lundbeck: acquisitions must be well considered

Lundbeck is currently on the hunt for buying opportunities, but deals must be closed with consideration, says CEO Deborah Dunsire.

Lundbeck CEO Deborah Dunsire | Photo: Gregers Tycho/ERH

Lundbeck is still on the lookout for something which can strengthen its pipeline with external projects or technology, and it is broadly looking to enhance its early and most recent pipeline.

However, agreements must be closed with great consideration and care, according to Lundbeck Chief Executive Deborah Dunsire.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs